Myrica salicifolia Hochst. ex A. Rich. suppress acetic acid-induced ulcerative colitis in rats by reducing TNF-alpha and interleukin-6, oxidative stress parameters and improving mucosal protection
Open Access
- 13 May 2022
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) with rising prevalence in developing countries, and limited success of current therapies, natural products have immense potential for therapy due to their “disease modifying and side-effect neutralizing” potential. Myrica salicifolia is traditionally used for gastrointestinal diseases and have reported antiinflammatory activities, but its use in IBD has not yet been studied. Therefore, in the present study, the effects of the root extract of M. salicifolia (Ms.Cr) were investigated using the acetic acid-induced UC model in rats. For 6 days, the rats were given either vehicle (10 mL/kg), lower (200 mg/kg), and higher (400 mg/kg) doses of Ms.Cr, or the positive control drug (prednisolone; 2 mg/kg) orally. A single dosage of 5% acetic acid (1.0 mL) was administered intrarectally to rats on day 6 to induce UC. Disease activity index (DAI), histological observations, the biochemical parameters related to oxidative stress, and specific cytokines such as interleukin-6 (IL-6) and the tumor necrosis factor-α (TNF-α) were determined to assess the effect of Ms.Cr. In comparison to the AA-induced colitis rats, Ms.Cr’s pretreatment significantly decreased DAI, colonic ulceration, and inflammatory score. Total glutathione levels and catalase activity were considerably recovered in the colitis group treated with Ms.Cr, whereas enhanced lipid peroxidation in colon tissues was significantly decreased. Moreover, Ms.Cr pretreatment also caused inhibition of the activation of IL-6 and TNF-α in the colonic tissues of respective groups. Based on these findings, Ms.Cr might be developed to treat UC in the future.Keywords
This publication has 51 references indexed in Scilit:
- Mucosal Barrier in Ulcerative Colitis and Crohn’s DiseaseGastroenterology Research and Practice, 2013
- Mechanisms underlying the antidiarrheal, antispasmodic and bronchodilator activities of Fumaria parviflora and involvement of tissue and species specificityJournal of Ethnopharmacology, 2012
- Effect of Boswellia serrata on Antioxidant Status in an Experimental Model of Colitis Rats Induced by Acetic AcidDigestive Diseases and Sciences, 2012
- On the Relationship between Sialomucin and Sulfomucin Expression and Hydrogenotrophic Microbes in the Human Colonic MucosaPLOS ONE, 2011
- Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine modelFood and Chemical Toxicology, 2009
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007
- Benefits ofZataria multiflora Boissin Experimental Model of Mouse Inflammatory Bowel DiseaseEvidence-Based Complementary and Alternative Medicine, 2007
- Lipid peroxides in patients with inflammatory bowel diseaseSaudi Journal of Gastroenterology, 2007
- Handbook of Methods for Oxygen Radical ResearchJournal of Pediatric Gastroenterology and Nutrition, 1988